Companies race to get ahead of Trump tariffs

PTC Therapeutics Ends Utreloxastat Development After Rare Neurodegenerative Disease Trial Misses Goal, Analyst Maintains Outperform With Focus On Sepiapterin, Huntington’s Programs

Goldman sees ‘significant’ hit to U.S. from Trump’s Canada tariffs

Hidden Flaws That Frequently Mess Up Estate Plans

Who Is Jay Bhattacharya? The Lockdown Critic And ‘Herd Immunity’ Backer Picked To Lead NIH.